Fenghai DuanAssociate Professor of Biostatistics (Research)
Dr. Duan obtained his PhD in Biostatistics from Yale University in 2005. He joined the faculty in the Department of Biostatistics and Center for Statistical Sciences at Brown University in 2008. He is primarily working in the Biostatistical Center of ACRIN (American College of Radiology Imaging Network), conducting clinical cancer research to explore the role of medical imaging and image-guided therapy in the diagnosis and treatment of cancer. His research interests include high dimensional data analysis, computational molecular biology, bioinformatics and diagnostic test evaluation.
Dr. Duan's research interests include high dimensional data analysis (in particular cancer signature’s discovery), computational molecular biology, bioinformatics and diagnostic test evaluation in clinical trials.
Dr. Duan's research interests include high dimensional data analysis (in particular cancer signature’s discovery), computational molecular biology, bioinformatics and diagnostic test evaluation. Dr. Duan has successfully collaborated with investigators on several grants that focus on the identification of molecular signatures for a variety of diseases (mostly cancers). In particular, Dr. Duan has co-authored several papers on the research of rhabdomyosarcoma’s genomics, including the study of gene fusion, chromosome amplification, and microRNA’s in the association with clinical outcome. Since he joined the Department of Biostatistics at Brown University, Dr. Duan primarly works on diagnostic test evaluation for clinical trials sponsored by the American College of Radiology Imaging Network (ACRIN) (Now ECOG-ACRIN). Currently, he is the lead statistician for a number of clinical trials, varying across different cancer types and imaging modailities. He is also the lead statistician for NLST-ACRIN biorepository and is currently working with the DECAMP consortium on studies of molecular and imaging biomarkers for lung cancer. Aside from the ACRIN studies, Dr. Duan is the statistician for the National Oncologic PET Registry (NOPR), a nationwide prospective internet-based registry with the primary goal of assessing the effect of PET on referring physicians’ plans of intended patient management. Dr. Duan has publications on the journals of New England Journal of Medicine, Journal of Clinical Oncology, Radiology, Journal of Nuclear Medicine, Clinical Cancer Research, Bioinformatics, BMC Genomics, and so on.
Detection of Early Lung Cancer Among Military Personnel (DECAMP)